Evaluation of anticancer medicinal products in man - addendum on paediatric oncology

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/EWP/569/02
Published24/01/2003
Effective from01/01/2004
KeywordsChildhood cancer, childhood malignancy, predictive model systems, xenograft models
DescriptionThis document is an addendum to the guideline on evaluation of anticancer medicinal products in man. It aims to complement the current guideline with specific regulatory requirements related to paediatric oncology. It provides more specific information on the design and conduct of phase I trials in padiatric patients.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more